ROD LEWIS: Open Payments
NPI 1043523897 · DALTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 54 payments from 17 companies in 2025. Trend: 2023 $928 · 2024 $947 · 2025 $1,029
Food & beverage: $1,029
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $200 |
| Lilly USA, LLC | 10 | $187 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $118 |
| PFIZER INC. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $61 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
Products named: VRAYLAR, JARDIANCE, CAPLYTA, REXULTI, Auvelity, VOQUEZNA, GVOKE HYPOPEN, ELIQUIS.
Industry payments across GA — which companies pay providers there.
